Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges
- sbcopioidtaskforce
- Nov 16, 2022
- 1 min read
June 5, 2019
The opioid manufacturer Insys Therapeutics agreed to pay $225 million to settle federal criminal and civil charges that it illegally marketed a highly addictive fentanyl painkiller to doctors, federal prosecutors said on Wednesday.
Comments